Squarepoint
HZNP

Squarepoint’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Squarepoint’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-67,100
Closed -$7.76M – 4664
2023
Q3 		$7.76M Buy
67,100
+60,000
+845% +$6.45M 0.02% 917
2023
Q2 		$730K Hold
7,100
– – ﹤0.01% 2393
2023
Q1 		$775K Hold
7,100
– – ﹤0.01% 2055
2022
Q4 		$808K Sell
7,100
-500
-7% -$41.5K ﹤0.01% 1979
2022
Q3 		$470K Buy
+7,600
New +$531K ﹤0.01% 2230

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Squarepoint's HZNP Position: Q3 2023 in Review

Squarepoint sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 93,928 shares — an estimated $10.1M sold.

Squarepoint first reported a position in HZNP in Q2 2015 and held it in 26 quarters. The position peaked at $24.9M in Q4 2021. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

  • Squarepoint reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Squarepoint sold 93,928 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $10.1M.
  • Squarepoint first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 26 quarters.
  • Squarepoint's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $24.9M in Q4 2021.
  • 485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Squarepoint's 13F filing for Q3 2023, filed 14 Nov 2023.